BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS

Diabetes Clinical Trial

Official title:

BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS ON METFORMIN THERAPY IN A WEST AFRICA SUB-REGION

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02505516
• Other study ID #: 021
• Status: Completed
• Phase: Phase 0
• First received: July 20, 2015
• Last updated: July 21, 2015
• Start date: June 2013
• Est. completion date: February 2014

Study information

• Verified date: July 2015
• Source: University of Cape Coast
• Contact: n/a
• Is FDA regulated: No
• Health authority: Ghana: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

patients om metformin from diabetic clinic were checked for bladder cancer

Recruitment information / eligibility

• Status: Completed
• Enrollment: 150
• Est. completion date: February 2014
• Est. primary completion date: January 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 25 Years to 86 Years

Eligibility

Inclusion Criteria:

• 150 people attending diabetic clinic

Exclusion Criteria:

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Screening

Related Conditions & MeSH terms

• Bladder Cancer
• Diabetes
• Urinary Bladder Neoplasms

Intervention

Other:
• metformin

Locations

Country	Name	City	State
Ghana	Universty of Capecoast	Cape Coast

Sponsors (1)

Lead Sponsor	Collaborator
UFUOMA MILLER FAKPOR

Country where clinical trial is conducted

Ghana, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of diabetic patients on metformin therapy		6 months	Yes